FREEZE-AFIB Post-Market Study

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

April 29, 2022

Primary Completion Date

March 31, 2023

Study Completion Date

December 31, 2023

Conditions
Atrial FibrillationAtrial Flutter
Interventions
DEVICE

Surgical Ablation

The AtriCure cryoICE® cryoFORMTM cryoablation probe is used in the cryosurgical treatment of cardiac arrhythmias by freezing target tissues, creating an inflammatory response (cryonecrosis) that blocks the electrical conduction pathway.

Trial Locations (6)

19107

Thomas Jefferson University Hospital, Philadelphia

37205

Saint Thomas West Hospital, Nashville

48109

University of Michigan, Ann Arbor

60208

Northwestern University, Evanston

06106

Hartford Hospital, Hartford

06510

Yale University School of Medicine, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AtriCure, Inc.

INDUSTRY

NCT05089877 - FREEZE-AFIB Post-Market Study | Biotech Hunter | Biotech Hunter